Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
2001 1
2003 1
2004 2
2005 2
2008 1
2010 1
2011 1
2013 1
2014 3
2015 2
2016 2
2017 4
2018 8
2019 2
2020 3
2021 1
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
Swen JJ, van der Wouden CH, Manson LE, Abdullah-Koolmees H, Blagec K, Blagus T, Böhringer S, Cambon-Thomsen A, Cecchin E, Cheung KC, Deneer VH, Dupui M, Ingelman-Sundberg M, Jonsson S, Joefield-Roka C, Just KS, Karlsson MO, Konta L, Koopmann R, Kriek M, Lehr T, Mitropoulou C, Rial-Sebbag E, Rollinson V, Roncato R, Samwald M, Schaeffeler E, Skokou M, Schwab M, Steinberger D, Stingl JC, Tremmel R, Turner RM, van Rhenen MH, Dávila Fajardo CL, Dolžan V, Patrinos GP, Pirmohamed M, Sunder-Plassmann G, Toffoli G, Guchelaar HJ; Ubiquitous Pharmacogenomics Consortium. Swen JJ, et al. Among authors: guchelaar hj. Lancet. 2023 Feb 4;401(10374):347-356. doi: 10.1016/S0140-6736(22)01841-4. Lancet. 2023. PMID: 36739136 Clinical Trial.
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies.
Guchelaar NAD, Noordman BJ, Koolen SLW, Mostert B, Madsen EVE, Burger JWA, Brandt-Kerkhof ARM, Creemers GJ, de Hingh IHJT, Luyer M, Bins S, van Meerten E, Lagarde SM, Verhoef C, Wijnhoven BPL, Mathijssen RHJ. Guchelaar NAD, et al. Drugs. 2023 Feb;83(2):159-180. doi: 10.1007/s40265-022-01828-7. Epub 2023 Jan 12. Drugs. 2023. PMID: 36633826 Free PMC article. Review.
The role of pharmacogenetics in the treatment of osteosarcoma.
Vos HI, Coenen MJ, Guchelaar HJ, Te Loo DM. Vos HI, et al. Among authors: guchelaar hj. Drug Discov Today. 2016 Nov;21(11):1775-1786. doi: 10.1016/j.drudis.2016.06.022. Epub 2016 Jun 25. Drug Discov Today. 2016. PMID: 27352631 Review.
RAINFOREST: a random forest approach to predict treatment benefit in data from (failed) clinical drug trials.
Ubels J, Schaefers T, Punt C, Guchelaar HJ, de Ridder J. Ubels J, et al. Among authors: guchelaar hj. Bioinformatics. 2020 Dec 30;36(Suppl_2):i601-i609. doi: 10.1093/bioinformatics/btaa799. Bioinformatics. 2020. PMID: 33381829
Data from this study can be obtained upon request. Requests should be directed toward Prof. Dr. H.J. Guchelaar (h.j.guchelaar@lumc.nl). SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online....
Data from this study can be obtained upon request. Requests should be directed toward Prof. Dr. H.J. Guchelaar (h.j …
Medication errors: hospital pharmacist perspective.
Guchelaar HJ, Colen HB, Kalmeijer MD, Hudson PT, Teepe-Twiss IM. Guchelaar HJ, et al. Drugs. 2005;65(13):1735-46. doi: 10.2165/00003495-200565130-00001. Drugs. 2005. PMID: 16114974 Review.
Individualized dosing of tyrosine kinase inhibitors: are we there yet?
de Wit D, Guchelaar HJ, den Hartigh J, Gelderblom H, van Erp NP. de Wit D, et al. Among authors: guchelaar hj. Drug Discov Today. 2015 Jan;20(1):18-36. doi: 10.1016/j.drudis.2014.09.007. Epub 2014 Sep 22. Drug Discov Today. 2015. PMID: 25245169 Review.
36 results